BioNTech posts $3.6B net profit
BioNTech, the German pharmaceutical company that teamed with Pfizer to develop the first widely used COVID-19 vaccine, on Wednesday reported strongquarterly earnings growth on pandemic-fueled demand. The company posted net profit of nearly $3.6 billion for the final three months of 2021, up from $409 million in the same period the previous year. Quarterly revenue … Read more